Biblio

Export 924 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is F  [Clear All Filters]
Journal Article
M. Haddad, Perrotte, M., Landri, S., Lepage, A., Fülöp, T., and Ramassamy, C., “Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 69, no. 3, pp. 751-762, 2019.
L. S. Nidadavolu, Feger, D., Wu, Y., Grodstein, F., Gross, A. L., Bennett, D. A., Walston, J. D., Oh, E. S., and Abadir, P. M., “Circulating Cell-Free Genomic DNA Is Associated with an Increased Risk of Dementia and with Change in Cognitive and Physical Function.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1233-1240, 2022.
D. Bergeron, Beauregard, J. - M., Guimond, J., Fortin, M. - P., Houde, M., Poulin, S., Verret, L., Bouchard, R. W., and Laforce, R., “Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes.”, J Alzheimers Dis, vol. 49, no. 3, pp. 695-705, 2016.
E. Morenas-Rodriguez, Sala, I., Subirana, A., Pascual-Goñi, E., Sánchez-Saudinós, M. Belén, Alcolea, D., Illán-Gala, I., Carmona-Iragui, M., Ribosa-Nogué, R., Camacho, V., Blesa, R., Fortea, J., and Lleo, A., “Clinical Subtypes of Dementia with Lewy Bodies Based on the Initial Clinical Presentation.”, J Alzheimers Dis, vol. 64, no. 2, pp. 505-513, 2018.
G. M. Sancesario, Toniolo, S., Chiasserini, D., Di Santo, S. G., Zegeer, J., Bernardi, G., Musicco, M., Caltagirone, C., Parnetti, L., and Bernardini, S., “The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1659-1666, 2017.
G. M. Sancesario, Toniolo, S., Chiasserini, D., Di Santo, S. G., Zegeer, J., Bernardi, G., Musicco, M., Caltagirone, C., Parnetti, L., and Bernardini, S., “The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1659-1666, 2017.
M. Reda Bensaïdane, Beauregard, J. - M., Poulin, S., Buteau, F. - A., Guimond, J., Bergeron, D., Verret, L., Fortin, M. - P., Houde, M., Bouchard, R. W., Soucy, J. - P., and Laforce, R., “Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1251-62, 2016.
F. Verde, Aiello, E. Nicolò, Adobbati, L., Poletti, B., Solca, F., Tiloca, C., Sangalli, D., Maranzano, A., Muscio, C., Ratti, A., Zago, S., Ticozzi, N., Frisoni, G. Battista, and Silani, V., “Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the Literature.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1383-1399, 2023.
J. M. Walker, Gonzales, M. M., Goette, W., Farrell, K., Iii, C. L. White, Crary, J. F., and Richardson, T. E., “Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1037-1049, 2023.
C. Rattanabannakit, Risacher, S. L., Gao, S., Lane, K. A., Brown, S. A., McDonald, B. C., Unverzagt, F. W., Apostolova, L. G., Saykin, A. J., and Farlow, M. R., “The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1145-55, 2016.
C. E. Gleason, Fischer, B. L., N Dowling, M., Setchell, K. D. R., Atwood, C. S., Carlsson, C. M., and Asthana, S., “Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 4, pp. 1009-19, 2015.
P. Martín-Jiménez, Muñoz-García, M. I., Seoane, D., Roca-Rodríguez, L., García-Reyne, A., Lalueza, A., Maestro, G., Folgueira, D., Blanco-Palmero, V. A., San Martín, A. Herrero-, Llamas-Velasco, S., Pérez-Martínez, D. A., González-Sánchez, M., and Villarejo-Galende, A., “Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1367-1372, 2020.
S. Angermann, Schier, J., Baumann, M., Steubl, D., Hauser, C., Lorenz, G., Günthner, R., Braunisch, M. C., Kemmner, S., Satanovskij, R., Haller, B., Heemann, U., Lehnert, T., Bieber, R., Pachmann, M., Braun, J., Scherf, J., Schätzle, G., Fischereder, M., Grimmer, T., and Schmaderer, C., “Cognitive Impairment is Associated with Mortality in Hemodialysis Patients.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1529-1537, 2018.
L. Xiong, Davidsdottir, S., Reijmer, Y. D., Shoamanesh, A., Roongpiboonsopit, D., Thanprasertsuk, S., Martinez-Ramirez, S., Charidimou, A., Ayres, A. M., Fotiadis, P., Gurol, E., Blacker, D. L., Greenberg, S. M., and Viswanathan, A., “Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit.”, J Alzheimers Dis, vol. 52, no. 1, pp. 171-8, 2016.
J. Middelstädt, Folkerts, A. - K., Blawath, S., and Kalbe, E., “Cognitive Stimulation for People with Dementia in Long-Term Care Facilities: Baseline Cognitive Level Predicts Cognitive Gains, Moderated by Depression.”, J Alzheimers Dis, vol. 54, no. 1, pp. 253-68, 2016.
M. Balietti, Giuli, C., Fattoretti, P., Fabbietti, P., Postacchini, D., and Conti, F., “Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 4, pp. 957-62, 2016.
M. Balietti, Giuli, C., Fattoretti, P., Fabbietti, P., Postacchini, D., and Conti, F., “Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 4, pp. 957-62, 2016.
K. Ritter, Lange, C., Weygandt, M., Mäurer, A., Roberts, A., Estrella, M., Suppa, P., Spies, L., Prasad, V., Steffen, I., Apostolova, I., Bittner, D., Gövercin, M., Brenner, W., Mende, C., Peters, O., Seybold, J., Fiebach, J. B., Steinhagen-Thiessen, E., Hampel, H., Haynes, J. - D., and Buchert, R., “Combination of Structural MRI and FDG-PET of the Brain Improves Diagnostic Accuracy in Newly Manifested Cognitive Impairment in Geriatric Inpatients.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1319-1331, 2016.
S. Nabirotchkin, Bouaziz, J., Glibert, F., Mandel, J., Foucquier, J., Hajj, R., Callizot, N., Cholet, N., Guedj, M., and Cohen, D., “Combinational Drug Repurposing from Genetic Networks Applied to Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1585-1603, 2022.
S. Mazzeo, Santangelo, R., Bernasconi, M. Paola, Cecchetti, G., Fiorino, A., Pinto, P., Passerini, G., Falautano, M., Comi, G., and Magnani, G., “Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1495-1508, 2016.
S. Mazzeo, Santangelo, R., Bernasconi, M. Paola, Cecchetti, G., Fiorino, A., Pinto, P., Passerini, G., Falautano, M., Comi, G., and Magnani, G., “Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1495-1508, 2016.
N. M. Payton, Kalpouzos, G., Rizzuto, D., Fratiglioni, L., Kivipelto, M., Bäckman, L., and Laukka, E. J., “Combining Cognitive, Genetic, and Structural Neuroimaging Markers to Identify Individuals with Increased Dementia Risk.”, J Alzheimers Dis, vol. 64, no. 2, pp. 533-542, 2018.
G. Tell-Marti, Puig-Butille, J. Anton, Potrony, M., Plana, E., Badenas, C., Antonell, A., Sánchez-Valle, R., Molinuevo, J. L., Lleo, A., Alcolea, D., Fortea, J., Fernández-Santiago, R., Clarimón, J., Lladó, A., and Puig, S., “A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1065-1074, 2017.
G. Tell-Marti, Puig-Butille, J. Anton, Potrony, M., Plana, E., Badenas, C., Antonell, A., Sánchez-Valle, R., Molinuevo, J. L., Lleo, A., Alcolea, D., Fortea, J., Fernández-Santiago, R., Clarimón, J., Lladó, A., and Puig, S., “A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1065-1074, 2017.
P. C. G. Haddick, Larson, J. L., Rathore, N., Bhangale, T. R., Phung, Q. T., Srinivasan, K., Hansen, D. V., Lill, J. R., Pericak-Vance, M. A., Haines, J., Farrer, L. A., Kauwe, J. S., Schellenberg, G. D., Cruchaga, C., Goate, A. M., Behrens, T. W., Watts, R. J., Graham, R. R., Kaminker, J. S., and van der Brug, M., “A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1037-1054, 2017.

Pages